
    
      This is a single group assignment study with a total of 9 knee osteoarthritis patients
      participants. All of the patients will receive the anticular injection with MSCs from
      umbilical cord and unexplained local and systemic symptoms or death before the end of
      following-up will be assessed to evaluate the safety and efficacy of mesenchymal stem cells
      from umbilical cord.
    
  